ID: 199
Titel: A Phase I/II, open label, and multicenter study of the safety, efficacy and immune response of histamine dihydrochloride and low-dose interleukin-2 in chronic myelomonocytic leukemia (CMML)
Provsamlingsansvarig: Lars Möllgård
Start insamling: -
Slut insamling: -
Beskrivning: Multiccenter studie

PROVTYP;PROVGIVARE
Benmärg;15
Blodprov;15